CAS 285983-48-4
:Doramapimod
Description:
Doramapimod, with the CAS number 285983-48-4, is a small molecule inhibitor primarily targeting the p38 mitogen-activated protein kinase (MAPK) pathway. This compound is notable for its potential therapeutic applications, particularly in inflammatory diseases and certain cancers. Doramapimod exhibits anti-inflammatory properties by inhibiting the phosphorylation of downstream targets involved in the inflammatory response. Its chemical structure includes a specific arrangement of functional groups that contribute to its biological activity and selectivity for the p38 MAPK isoforms. The substance has undergone various preclinical and clinical studies to evaluate its efficacy and safety profile. As a research chemical, Doramapimod serves as a valuable tool for understanding the role of p38 MAPK in cellular processes and disease mechanisms. However, like many investigational drugs, its clinical use is subject to ongoing research and regulatory approval.
Formula:C31H37N5O3
InChI:InChI=1/C31H37N5O3/c1-22-9-11-23(12-10-22)36-29(21-28(34-36)31(2,3)4)33-30(37)32-26-13-14-27(25-8-6-5-7-24(25)26)39-20-17-35-15-18-38-19-16-35/h5-14,21H,15-20H2,1-4H3,(H2,32,33,37)
InChI key:InChIKey=MVCOAUNKQVWQHZ-UHFFFAOYSA-N
SMILES:N(C(NC=1C2=C(C(OCCN3CCOCC3)=CC1)C=CC=C2)=O)C=4N(N=C(C(C)(C)C)C4)C5=CC=C(C)C=C5
Synonyms:- 1-(3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-3-(4-(2-(morpholin-4-yl)ethoxy)naphthalen-1-yl)urea
- 1-[2-(4-Methylphenyl)-5-tert-butyl-pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea
- 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea
- 1-[5-Tert-Butyl-2-(4-Methylphenyl)Pyrazol-3-Yl]-3-[4-(2-Morpholin-4-Ylethoxy)Naphthalen-1-Yl]Urea
- Birb 796
- Birb 796Bs
- Brb 796
- N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N′-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea
- Unc 10225354
- Unc10225354
- Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N′-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-
- Doramapimod
- BIRB 796 (DoraMapiMod)
- 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholinoethoxy)-1-naphthyl]urea
- BIBR-796(DoraMapiMod)
- DoraMapiMod, BIBR-796
- DoraMapin BIBR796
- 1-[2-(4-Methylphenyl)-5-tert-butyl-pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea BIRB 796 (Doramapimod)
- DoraMapiMod (BIRB-796)
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-
CAS:Formula:C31H37N5O3Purity:99%Color and Shape:SolidMolecular weight:527.6572Doramapimod
CAS:Formula:C31H37N5O3Purity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:527.67Doramapimod
CAS:<p>Doramapimod</p>Formula:C31H37N5O3Purity:99.9% (Typical Value in Batch COA)Color and Shape: off-white solidMolecular weight:527.65718g/molDoramapimod
CAS:<p>Doramapimod (BIRB 796) is a highly potent inhibitor of p38 MAPK (Kd: 0.1 nM), but weakly inhibits c-RAF, Fyn, Lck, ERK-1, SYK, IKK2, and ZAP-70.</p>Formula:C31H37N5O3Purity:97.14% - 98.80%Color and Shape:SolidMolecular weight:527.66Doramapimod
CAS:Controlled Product<p>Applications Doramapimod is a highly potent inhibitor of p38 mitogen-activated protein kinase (MAPK). Doramapimod is a potential agent for the treatment of inflammatory diseases. Doramapimod blocks baseline and bortezomib-triggered upregulation of p38 MAPK and Hsp27 phosphorylation leading to enhanced cytotoxicity and caspase activation.<br>References Pargellis, C. et al.: Nat. Struct. Biol., 9, 268 (2002,); Kuma, Y. et al.: J. Biol. CHem., 280, 19472 (2005); Yasui, H. et al.: Br. J. Haematol., 136, 414 (2007);<br></p>Formula:C31H37N5O3Color and Shape:NeatMolecular weight:527.66Doramapimod
CAS:<p>p38α MAP kinase inhibitor; JNK2α2 protein kinase inhibitor</p>Formula:C31H37N5O3Purity:Min. 95%Color and Shape:PowderMolecular weight:527.66 g/mol





